2020 American Society of Hematology Virtual Annual Meeting*

December 5-8, 2020; Online at https://www.hematology.org/meetings/annual-meeting
Review slidesets and expert analyses of key data from the 2020 Hematology Virtual Annual Meeting!
Hanny Al-Samkari, MD
John M. Burke, MD
Jorge Cortes, MD
Amy E. DeZern, MD, MHS
Shaji Kumar, MD
Sagar Lonial, MD
Mark A. Schroeder, MD
Jeff P. Sharman, MD
Sujit Sheth, MD
Srdan Verstovsek, MD, PhD
Eunice S. Wang, MD

ClinicalThought

Review experts' perspectives on the most clinically relevant data on malignant and nonmalignant hematology results to be presented at the ASH 2020 annual meeting, including key insights and the latest data you need to understand and integrate into your practice.

Hanny Al-Samkari, MD John M. Burke, MD Jorge Cortes, MD Amy E. DeZern, MD, MHS Shaji Kumar, MD Sagar Lonial, MD Mark A. Schroeder, MD Jeff P. Sharman, MD Sujit Sheth, MD Srdan Verstovsek, MD, PhD Eunice S. Wang, MD Released: December 2, 2020

Lymphomas and Chronic Lymphocytic Leukemia

Multiple Myeloma

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Amgen
AstraZeneca
Bristol-Myers Squibb
Epizyme Inc.
GlaxoSmithKline
Incyte Corporation
Janssen Biotech
Karyopharm Therapeutics Inc.
Novartis
PharmaEssentia Corp.
Seattle Genetics
Takeda Oncology

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue